Filing Details

Accession Number:
0000899243-22-039167
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-21 16:05:28
Reporting Period:
2022-12-19
Accepted Time:
2022-12-21 16:05:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
31791 Perkinelmer Inc PKI Laboratory Analytical Instruments (3826) 042052042
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1408107 S Tajinder Vohra 940 Winter Street
Waltham MA 02451
Please See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-19 1,662 $48.98 18,867 No 4 M Direct
Common Stock Disposition 2022-12-19 901 $138.13 17,966 No 4 S Direct
Common Stock Disposition 2022-12-19 761 $139.04 17,205 No 4 S Direct
Common Stock Acquisiton 2022-12-20 1,663 $48.98 18,868 No 4 M Direct
Common Stock Disposition 2022-12-20 90 $136.96 18,778 No 4 S Direct
Common Stock Disposition 2022-12-20 632 $138.51 18,146 No 4 S Direct
Common Stock Disposition 2022-12-20 941 $139.26 17,205 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock NQ Stock Option (right to buy) Disposition 2022-12-19 1,662 $0.00 1,662 $48.98
Common Stock NQ Stock Option (right to buy) Disposition 2022-12-20 1,663 $0.00 1,663 $48.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,988 2023-03-04 No 4 M Direct
3,325 2023-03-04 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Vohra on November 16, 2022.
  2. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $137.60 to $138.43. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  3. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $138.82 to $139.32. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  4. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $138.03 to $138.81. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  5. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $139.07 to $139.49. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  6. This option became exercisable in three equal annual installments beginning on March 4, 2017, which was the first anniversary of the date on which the option was granted.